SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-005872
Filing Date
2018-04-27
Accepted
2018-04-27 16:06:38
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 360133
2 ex31-1.htm EX-31.1 16359
3 ex32-1.htm EX-32.1 5467
  Complete submission text file 0001493152-18-005872.txt   2380068

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20180331.xml EX-101.INS 352647
5 XBRL SCHEMA FILE lixt-20180331.xsd EX-101.SCH 39290
6 XBRL CALCULATION FILE lixt-20180331_cal.xml EX-101.CAL 27304
7 XBRL DEFINITION FILE lixt-20180331_def.xml EX-101.DEF 146912
8 XBRL LABEL FILE lixt-20180331_lab.xml EX-101.LAB 244608
9 XBRL PRESENTATION FILE lixt-20180331_pre.xml EX-101.PRE 185390
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 18783874
SIC: 2834 Pharmaceutical Preparations